Skip to main content
Caplight Logo









Liberum Biotech

Liberum Biotech

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://liberumbio.com/

Last Round

Seed

Jul 24, 2023

Total Funding Raised

$2.05M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Liberum Biotech is a biotechnology company that provides a cell-free protein synthesis platform to accelerate protein and antibody discovery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Infrastructure

Keywords

cell-free protein synthesisprotein synthesis serviceCFPSprotein prototypingprotein engineeringprotein printingbio-foundryenzyme discoveryantibody discoverylab-in-the-loopsequence-to-function dataAI protein designbiotech equipmentbenchtop protein synthesiscell-free expressionnanobody expression

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Liberum Biotech Comparables

Compare Liberum Biotech with similar companies based on industry and business-model similarity.

Liberum Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Tierra Biosciences
90%
Adaptyv Bio
84%
LenioBio
81%

Liberum Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 24, 2023
AcceleratorJun 11, 2020

Key People

Founding team and executive leadership

Alexander Klenov

Chief Technology Officer And Co-Founder

Founding Team

Liberum Biotech Investors

Notable investors and investment history

Liberum Biotech investors
InvestorRounds
TechU VenturesSeed
Creative Destruction LabAccelerator
VelocityAccelerator
IndieBioAccelerator
Savantus VenturesSeed
SOSVAccelerator, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 108% MoM, reaching 214.

  • Jan 1, 2026

    Monthly visitors increased 207% MoM to 3.9K.

Liberum Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Liberum Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Liberum Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range7
Year Founded2019
Last FundingJul 24, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?